Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant

Pediatrics International

Volumn 52, Issue 5, 2010, Pages 838-841

  Asahina, Naoko ^a   Matsunami, Yukiko ^b   Sueda, Keitaro ^a   Shiraishi, Hideaki ^a   Saitoh, Shinji ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KKR Sapporo Medical Center   (Japan)

Author keywords

oral poliovirus vaccine; poliomyelitis; primary immunodeficiencies; tissue injury; vaccine associated paralytic poliomyelitis

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; ORAL POLIOMYELITIS VACCINE;

ARTICLE; CASE REPORT; FLACCID PARALYSIS; HUMAN; IMMUNE DEFICIENCY; INFANT; MALE; PERIANAL ABSCESS; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION; VACCINE ASSOCIATED PARALYTIC POLIOMYELITIS;

FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPETENCE; INFANT; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; NEURAL CONDUCTION; PARALYSIS; PHYSICAL THERAPY MODALITIES; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPINAL PUNCTURE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VACCINATION;

EID: 77957359660     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03132.x     Document Type: Article

References (12)

1. Yoneyama T, Karoji Y, Watanabe K, Tsuchiya M, Nakano M, Miyamura T. Surveillance of poliovirus-isolates in Japan, 1999. Jpn. J. Infect. Dis. 2000 53 : 90 1.
2. Global Commission for the Certification of the Eradication of Poliomyelitis. Meeting (2002: Geneva, Switzerland). Report of the Interim Meeting of the Technical Consultative Group (TCG) on the Global Eradication of Poliomyelitis, Geneva, 13-14 November 2002. World Health Organization, Geneva, 2003.
3. Parvaneh N, Shahmahmoudi S, Tabatabaie H et al. Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency. J. Clin. Virol. 2007 39 : 145 148.
4. Manishi S, Shahmahmoudi S, Tabatabaie H et al. Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis. Eur. J. Pediatr. 2008 167 : 1335 1338.
5. Hao L, Toyokawa S, Kobayashi Y. Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000. Jpn. J. Infect. Dis. 2008 61 : 100 103.
6. Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 1991 184 : 645 654.
7. Kornreich L, Dagan O, Grunebaum M. MRI in acute poliomyelitis. Neuroradiology 1996 38 : 371 372.
8. Strebel PM, Ion-Nedelcu N, Baughman AL, Sutter RW, Cochi SL. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine - a risk factor for vaccine associated paralytic poliomyelitis. N. Engl. J. Med. 1995 332 : 500 506.
9. Gromeier M, Wimmer E. Mechanism of injury-provoked poliomyelitis. J. Virol. 1998 72 : 5056 5060.
10. Bosley AR, Speirs G, Markham NI. Provocation poliomyelitis: vaccine associated paralytic poliomyelitis related to a rectal abscess in an infant. J. Infect. 2003 47 : 82 4.
11. American Academy of Pediatrics, Committee on Infectious Diseases. Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics 1999 104 : 1404 1406.
12. Alexander LN, Seward JF, Santibanez TA et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 2004 292 : 1696 1701.